Development of Ligand-Drug Conjugates Targeting Melanoma through the Overexpressed Melanocortin 1 Receptor. - Zhou Y; Mowlazadeh Haghighi S; Liu Z; Wang L; Hruby VJ; Cai M (ACS pharmacology & translational science, 2020)